ASTRO Virtual Meeting Center

Log-in / Create Account

Session Information

2010 Multidisciplinary Head and Neck Cancer Symposium

Click here to go to the previous page

General Session IV: Head and Neck Tumor Board

Track : General Sessions

Program Code: 05

Date: Thursday, February 25, 2010

Time: 3:30 PM to 5:00 PM EST

Duration: 90 Minutes

Location: Akimel 3-4 Ballroom

MODERATOR:

Click the plus sign to see more detailed information about each speaker.

Louis Harrison, Professor of Radiation Oncology, Albert Einstein College of Medicine, Continuum Cancer Centers of New York, Beth Israel Medical Center, St. Luke's and Roosevelt Hospitals, the Eye and Ear Infirmary, and Albert Einstein College of Medicine

Louis B. Harrison, MD, FASTRO, serves as the Clinical Director of Continuum Cancer Centers of New York as well as the Gerald J. Friedman Chair of Radiation Oncology at Beth Israel Medical Center and St. Lukes and Roosevelt Hospitals in New York. Continuum Cancer Centers is the combined programs of Beth Israel Medical Center, St. Lukes and Roosevelt Hospitals, and the New York Eye and Ear Infirmary. Dr. Harrison is an internationally recognized and extensively published expert in the areas of head and neck cancer, sarcomas, and intraoperative brachytherapy. He has been a leader in the development of multidisciplinary management strategies that prioritize cancer cure with organ and function preservation. He is co-editor of the award winning textbook Head and Neck Cancer, A Multidisciplinary Approach, now in its third edition. Dr. Harrison is Professor of Radiation Oncology at the Albert Einstein College of Medicine. Dr. Harrison received his M.D. degree from SUNY Downstate Medical Center in 1982 (Alpha Omega Alpha) and completed his residency training in Radiation Oncology at Yale in 1986. He has served ASTRO (American Society for Radiation Oncology) as President-Elect (2006), President (2007), Chairman of the Board (2008) and Immediate Past Chairman of the Board (2009). ASTRO is the largest professional society for radiation oncology in the world, and one of the leading professional cancer societies in the United States. In addition, he is a Past President of the American Brachytherapy Society (ABS) and the International Society of Intraoperative Radiation Therapy (ISIORT), as well as an active member of the American Head and Neck Society and the American Society of Clinical Oncology (ASCO). Dr. Harrison has been the recipient of the Clarence Dennis Society Prize for Surgical Scholarship, the Louise and Allston Boyer Award for Biomedical Research, the Ulrich Henschke Lecture Award for Brachytherapy, and the Distinguished Alumni Awards from SUNY Downstate College of Medicine as well as Poly Prep Country Day School.

SPEAKER(S):

Click the plus sign to see more detailed information about each speaker.

David Adelstein, M.D., Professor, Cleveland Clinic Foundation

I have been a medical oncologist with a focus on the management of aerodigestive tract cancer for the past 25 years. Recent publications: 1. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, Zuccaro G, Vargo JJ, Dumot JA, Carroll MA: A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: The impact of clinical heterogeneity. American Journal of Clinical Oncology 30:172-180, 2007. 2. Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA: Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Archives of Otolaryngology Head and Neck Surgery 133:435-440, 2007. 3. Adelstein DJ: Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: Current standards and future directions. International Journal of Radiation Oncology, Biology, Physics 69(Suppl.):S37-S39, 2007. 4. Kalmadi SR, Rankin C, Flaherty LE, Jacobs AD, Petrylak DP, Adelstein DJ, Keohan ML, Taub RN, Borden EC: Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810). Lung Cancer 2008 (in press). 5. Adelstein, DJ, Rodriguez CP: Current and emerging standards of concomitant chemoradiotherapy. Seminars in Oncology 35:211-220, 2008 6. Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Strome M, Esclamado RM, Lavertu P, Carroll MA: Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. Head and Neck (in press) 7. Mackley HB, Adelstein JS, Reddy CA, Adelstein DJ, Rice TW, Saxton JP, Videtic GMM: Does radiation planning modality impact outcomes in the treatment of locally advanced esophageal cancer? American Journal of Clinical Oncology (in press).

Robert Ferris, M.D., Ph.D., FACS, Professor, University of Pittsburgh Cancer Institute

Avraham Eisbruch, University of Michigan Medical Center

Lawrence Ginsberg, M.D., Professor, M.D. Anderson Cancer Center

Audio Synchronized to PowerPoint

(Code: 05)

Member:

Members Login